CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...
GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback